Douglas Clark is a copywriter and speechwriter with a healthy appetite for all things digital. He has more than 15 years' agency and independent experience in corporate and marketing communication, and his clients come from diverse industries, specializing in anything from financial products and toothpaste to software for the visualization of computational fluid dynamics data. Among his clients are Accenture, American Express, Coca-Cola, Colgate-Palmolive, Hewlett-Packard, and Panasonic.
Using the example of driving, this video puts risk reduction into perspective in a way most of us can relate to in everyday life.
Researchers use an ultrasound system to trigger responses in T cells, causing them to attack cancer cells.
As efficient as current platinum-based catalysts, the nanostructured composite material sidesteps costly platinum.
Computer modeling reveals the true potential of open-ocean wind farms, compared to conventional land-based wind farms.
The composite overcomes typical brittleness and shows potential for nuclear industry, oil and gas, aerospace applications.
Safety experts from LyondellBasell teach college professors from around the world about process safety.
Researchers have devised a single-atom alloy catalyst that requires significantly less energy to turn shale-gas methane into hydrocarbon fuels.
Scientists have devised a method that harnesses E. coli to potentially capture, store, or recycle carbon dioxide.
Engineers have discovered a catalyst that could prove useful in purifying water polluted with nitrates from agricultural runoff and other sources.
An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.
Each of us can have a role in reducing risk, whether in our personal lives, in the community around us, or in the institutions where we study and work.
Silver nanoparticles from clothing are ending up in waterways, but science is looking for ways to remove them.
The device aims to test and predict the effects of biological and chemical agents, diseases, or drugs on the brain without the need for human or animal subjects.